Morgan Stanley’s Zymergen Inc. Common Stock ZY Stock Holding History

Morgan Stanley’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,344,467	Closed	-$9.3M	–	8151
2022 Q3	$9.3M	Buy	3,344,467 +1,184,659	+55%	+$2.88M	﹤0.01%	3057
2022 Q2	$2.66M	Buy	2,159,808 +669,541	+45%	+$1.12M	﹤0.01%	4315
2022 Q1	$4.31M	Sell	1,490,267 -778,469	-34%	-$3.31M	﹤0.01%	3839
2021 Q4	$15.2M	Buy	2,268,736 +762,101	+51%	+$7.4M	﹤0.01%	2470
2021 Q3	$19.8M	Buy	1,506,635 +336,702	+29%	+$7.14M	﹤0.01%	2092
2021 Q2	$46.8M	Buy	+1,169,933	New	+$46.2M	0.01%	1360

Morgan Stanley's ZY Position: Q4 2022 in Review

Morgan Stanley sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 3,344,467 shares — an estimated $9.3M sold.

Morgan Stanley first reported a position in ZY in Q2 2021 and held it in 6 quarters. The position peaked at $46.8M in Q2 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

Morgan Stanley reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Morgan Stanley sold 3,344,467 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $9.3M.
Morgan Stanley first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 6 quarters.
Morgan Stanley's Zymergen Inc. Common Stock position peaked at $46.8M in Q2 2021.
0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.